Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat(R) KMT2A + MRD Assay and Software to its industry-leading ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The complexity of software architecture and diverse user interactions presents challenges to ...
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
SEngine Precision Medicine, the precision oncology innovator matching patients to medicines based on their own tumor samples, announces the publication of a new case report showing a patient’s ...
7d
Pioneering Reliability and Precision: The Rise of Top Environmental Testing Equipment Manufacturers
XIAN HIGH-TECH AREA, SHAANXI, CHINA, January 19, 2026 /EINPresswire.com/ -- With increasing demands for product ...
Large-scale infrastructure projects, interconnection schemes, and renewable energy developments continue to shape the ...
Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide: San Diego Friday, February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results